Literature DB >> 1849165

Varicella-zoster virus-specific immunity after herpes zoster.

A Hayward1, M Levin, W Wolf, G Angelova, D Gilden.   

Abstract

The frequency of varicella-zoster virus (VZV)-specific T lymphocytes was higher in elderly subjects who had herpes zoster infections than in age-matched controls. This increase in T cell response persisted for at least 2 years while antibody levels to VZV returned to control values at this time. There were no differences in T cell or antibody responses to VZV between individuals with and without postherpetic neuralgia. Elderly subjects who had not had herpes zoster had a comparable increase in VZV-specific T responder cell frequency after immunization with Oka strain VZV. The data suggest that the potential for a boost in T cell response to VZV persists in the elderly, and that immunization can elicit a T cell response in this age group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849165     DOI: 10.1093/infdis/163.4.873

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Viability and functional activity of cryopreserved mononuclear cells.

Authors:  A Weinberg; L Zhang; D Brown; A Erice; B Polsky; M S Hirsch; S Owens; K Lamb
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 2.  Treatment of postherpetic neuralgia: an update.

Authors:  G E Kanazi; R W Johnson; R H Dworkin
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

Review 3.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

4.  Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.

Authors:  Michael N Oxman; Anne A Gershon; Gregory A Poland
Journal:  Vaccine       Date:  2011-05-09       Impact factor: 3.641

5.  Construction of recombinant mouse IgG1 antibody directed against varicella zoster virus immediate early protein 63.

Authors:  Niklaus H Mueller; Laurie L Graf; Andrew J Shearer; Gregory P Owens; Donald H Gilden; Randall J Cohrs
Journal:  Hybridoma (Larchmt)       Date:  2008-02

6.  T cells increase before zoster and PD-1 expression increases at the time of zoster in immunosuppressed nonhuman primates latently infected with simian varicella virus.

Authors:  Stephanie F James; Vicki Traina-Dorge; Eileen Deharo; Mary Wellish; Brent E Palmer; Don Gilden; Ravi Mahalingam
Journal:  J Neurovirol       Date:  2014-02-19       Impact factor: 2.643

7.  Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia.

Authors:  Donald H Gilden; Randall J Cohrs; Anthony R Hayward; Mary Wellish; Ravi Mahalingam
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

8.  Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts.

Authors:  Randall J Cohrs; Satish K Mehta; D Scott Schmid; Donald H Gilden; Duane L Pierson
Journal:  J Med Virol       Date:  2008-06       Impact factor: 2.327

Review 9.  T-cell immunity to human alphaherpesviruses.

Authors:  Werner J D Ouwendijk; Kerry J Laing; Georges M G M Verjans; David M Koelle
Journal:  Curr Opin Virol       Date:  2013-05-08       Impact factor: 7.090

10.  Varicella-zoster virus in the saliva of patients with herpes zoster.

Authors:  Satish K Mehta; Stephen K Tyring; Donald H Gilden; Randall J Cohrs; Melanie J Leal; Victoria A Castro; Alan H Feiveson; C Mark Ott; Duane L Pierson
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.